Cargando…
Human Immature Dental Pulp Stem Cells Did Not Graft into a Preexisting Human Lung Adenocarcinoma
Mesenchymal stem cell (MSC)-based therapies have been considered an attractive approach for treating Huntington's disease (HD). However, due to the pulmonary first-passage effect associated with intravenous infusion (the most commonly used route of MSC administration), there is a rising concern...
Autores principales: | da Silva, Joyce Macedo, Araldi, Rodrigo Pinheiro, Colozza-Gama, Gabriel Avelar, Pagani, Eduardo, Sid, Ariye, Valverde, Cristiane Wenceslau, Kerkis, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149538/ https://www.ncbi.nlm.nih.gov/pubmed/35702561 http://dx.doi.org/10.1159/000523896 |
Ejemplares similares
-
Therapeutic Potential of Human Immature Dental Pulp Stem Cells Observed in Mouse Model for Acquired Aplastic Anemia
por: Gonzaga, Vivian Fonseca, et al.
Publicado: (2022) -
Restoration of BDNF, DARPP32, and D2R Expression Following Intravenous Infusion of Human Immature Dental Pulp Stem Cells in Huntington’s Disease 3-NP Rat Model
por: Wenceslau, Cristiane Valverde, et al.
Publicado: (2022) -
Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
por: da Costa, Vitor Rodrigues, et al.
Publicado: (2021) -
Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients
por: Araldi, Rodrigo Pinheiro, et al.
Publicado: (2022) -
Rat Facial Nerve Regeneration with Human Immature Dental Pulp Stem
Cells
por: Saez, Daniel Martinez, et al.
Publicado: (2019)